Edmund Waller | Immuno-Oncology | Best Researcher Award

Published on by Biotechnology Scientist

Prof. Dr. Edmund Waller | Immuno-Oncology |  Best Researcher Award

Lead Scientist at Cambium Oncology | United States

Prof. Dr. Edmund Waller demonstrates exceptional research excellence and global scientific impact, making him highly suitable for the Best Researcher Award. His contributions to hematology, oncology, and immunotherapy have significantly advanced understanding and clinical applications in stem cell transplantation and cancer treatment. With an outstanding Scopus profile reflecting 22,833 citations across 19,098 documents, 388 publications, and an h-index of 75, his work shows both high productivity and sustained scholarly influence. His research is widely recognized for its translational relevance, bridging laboratory discoveries with clinical outcomes, particularly in immune regulation and anti-tumor therapies. The consistency of high-impact publications and extensive citation record highlights his leadership in the field and the global adoption of his findings. Overall, his strong bibliometric indicators, innovative research contributions, and enduring academic influence clearly position him as a distinguished and deserving candidate for the Best Researcher Award.

Citation Metrics (Scopus)

23000

10000

1000

500

0

Citations
22,833

Documents
388

h-index
75

Citations

Documents

h-index

Featured Publications


Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma
SJ Schuster, MR Bishop, CS Tam, EK Waller, et al.
New England Journal of Medicine, 2019 Citations: 4518


A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning
S Miraglia, W Godfrey, AH Yin, et al.
Blood (American Society of Hematology), 1997 Citations: 1393


Peripheral-blood stem cells versus bone marrow from unrelated donors
C Anasetti, BR Logan, SJ Lee, EK Waller, et al.
New England Journal of Medicine, 2012 Citations: 1130


Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
D Miklos, CS Cutler, M Arora, EK Waller, et al.
Blood (American Society of Hematology), 2017 Citations: 592

Kwang Suk Lim | Cellular Immunotherapy | Best Researcher Award

Published on by Biotechnology Scientist

Prof. Kwang Suk Lim | Cellular Immunotherapy | Best Researcher Award

Associate Professor at Kangwon National University | South Korea

Dr. Kwang Suk Lim, Ph.D., is an accomplished biotechnology researcher whose work integrates molecular bioengineering, nanomedicine, and therapeutic innovation. As an Associate Professor at Kangwon National University, he leads cutting-edge research in polymeric biomaterials, gene delivery systems, and cancer immunotherapy. His recent focus includes non-genetic CAR-NK cell engineering, recombinant fusion protein development, and targeted chemo-immunotherapy strategies. Dr. Lim’s contributions to polymer-based drug delivery systems and environmental microplastic degradation highlight his broad scientific vision and practical impact. His research has been published in leading journals such as Pharmaceutics, Biomedicine & Pharmacotherapy, and Biotechnology and Bioprocess Engineering, earning him wide recognition in the biotechnology field. With 1,113 citations, an h-index of 17, and numerous peer-reviewed publications, Dr. Lim has demonstrated sustained academic excellence and innovation. His patented technologies on recombinant fusion proteins and immune-cell modification platforms underscore his translational research capacity. Dr. Lim’s interdisciplinary expertise and forward-looking research continue to shape modern biomedicine, making him an outstanding nominee for the Best Researcher Award in biotechnology.

Profiles : Google Scholar | ORCID

Featured Publications

Jin, J., Jeong, S. I., Shin, Y. M., Lim, K. S., Shin, H. S., Lee, Y. M., Koh, H. C., & Kim, K. S. (2009). Transplantation of mesenchymal stem cells within a poly(lactide‐co‐ɛ‐caprolactone) scaffold improves cardiac function in a rat myocardial infarction model. European Journal of Heart Failure, 11(2), 147–153. Cited by: 201

Won, Y. W., Adhikary, P. P., Lim, K. S., Kim, H. J., Kim, J. K., & Kim, Y. H. (2014). Oligopeptide complex for targeted non-viral gene delivery to adipocytes. Nature Materials, 13(12), 1157–1164. Cited by: 141

Won, Y. W., Lim, K. S., & Kim, Y. H. (2011). Intracellular organelle-targeted non-viral gene delivery systems. Journal of Controlled Release, 152(1), 99–109. Cited by: 90

Kang, Y. C., Son, M., Kang, S., Im, S., Piao, Y., Lim, K. S., Song, M. Y., Park, K. S., et al. (2018). Cell-penetrating artificial mitochondria-targeting peptide-conjugated metallothionein 1A alleviates mitochondrial damage in Parkinson’s disease models. Experimental & Molecular Medicine, 50(8), 1–13. Cited by: 76

Lim, K. S., Lee, D. Y., Valencia, G. M., Won, Y. W., & Bull, D. A. (2015). Nano‐self‐assembly of nucleic acids capable of transfection without a gene carrier. Advanced Functional Materials, 25(34), 5445–5451. Cited by: 60